- Home
- CCEL vs ANTX Comparison
CCEL vs ANTX Comparison
Compare CCEL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- ANTX
- Stock Information
- Founded
- CCEL 1989
- ANTX 2017
- Country
- CCEL United States
- ANTX United States
- Employees
- CCEL N/A
- ANTX N/A
- Industry
- CCEL Managed Health Care
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- CCEL Health Care
- ANTX Health Care
- Exchange
- CCEL Nasdaq
- ANTX Nasdaq
- Market Cap
- CCEL 34.8M
- ANTX 31.4M
- IPO Year
- CCEL 1997
- ANTX 2022
- Fundamental
- Price
- CCEL $4.44
- ANTX $1.25
- Analyst Decision
- CCEL Strong Buy
- ANTX Buy
- Analyst Count
- CCEL 1
- ANTX 2
- Target Price
- CCEL $8.50
- ANTX $2.00
- AVG Volume (30 Days)
- CCEL 27.1K
- ANTX 108.7K
- Earning Date
- CCEL 10-14-2025
- ANTX 11-12-2025
- Dividend Yield
- CCEL 13.27%
- ANTX N/A
- EPS Growth
- CCEL N/A
- ANTX N/A
- EPS
- CCEL N/A
- ANTX N/A
- Revenue
- CCEL $31,988,783.00
- ANTX N/A
- Revenue This Year
- CCEL $1.75
- ANTX N/A
- Revenue Next Year
- CCEL N/A
- ANTX N/A
- P/E Ratio
- CCEL N/A
- ANTX N/A
- Revenue Growth
- CCEL 1.10
- ANTX N/A
- 52 Week Low
- CCEL $4.09
- ANTX $0.98
- 52 Week High
- CCEL $9.43
- ANTX $1.68
- Technical
- Relative Strength Index (RSI)
- CCEL 45.46
- ANTX 59.38
- Support Level
- CCEL $4.20
- ANTX $1.05
- Resistance Level
- CCEL $4.70
- ANTX $1.33
- Average True Range (ATR)
- CCEL 0.20
- ANTX 0.08
- MACD
- CCEL 0.01
- ANTX 0.01
- Stochastic Oscillator
- CCEL 38.71
- ANTX 71.43
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.